ARTICLE | Company News
NovaDigm, Harbor-UCLA Medical Center deal
June 30, 2014 7:00 AM UTC
NovaDigm acquired exclusive, worldwide rights to Candida albicans hyphally regulated cell wall protein 1 ( Hyr1), a Candida vaccine antigen, from Harbor-UCLA Medical Center’s Los Angeles BioMedical R...